The global In-Vitro Diagnostics (IVD) industry has undergone a radical transformation. Post-pandemic, Respiratory Pathogen Panels (RPP) have moved from niche clinical tools to essential frontline diagnostic assets. As leading Respiratory Pathogen Panels Manufacturers, we recognize that the market is shifting from single-plex tests toward high-throughput, multiplex panels capable of detecting 20+ pathogens (viral, bacterial, and fungal) in a single run.
The global RPP market is projected to grow at a CAGR of over 8.5% through 2030. This growth is driven by the increasing incidence of respiratory infections, an aging global population, and the urgent need for "Syndromic Testing"—where clinicians test for a broad range of pathogens based on symptoms rather than guessing the specific virus.
Countries Served
Quality Standard
R&D Innovation
Technical Support
Integration of Artificial Intelligence and Machine Learning in digital microscopy and PCR interpretation is reducing human error. Our Smart Digital Microscopy Systems leverage AI for automated image analysis, ensuring rapid pathogen reporting with unmatched accuracy.
Point-of-Care Testing (POCT) is the new frontier. Factories are now focusing on miniaturizing Real-Time PCR systems to allow for on-site testing in clinics, airports, and remote areas, bypassing the need for centralized laboratories.
Modern panels are expanding beyond Influenza and COVID-19 to include Mycoplasma pneumoniae, RSV, and antibiotic-resistant bacterial markers, providing a comprehensive "one-stop" diagnostic result for complex respiratory cases.
For international buyers—hospitals, laboratory chains, and government health departments—procuring from reliable Respiratory Pathogen Panels Factories involves more than just price comparison. Reliability, cold-chain logistics, and regulatory compliance (CE, FDA, ISO) are paramount.
As a premier high-tech biotechnology company based in Ningbo, China, Ningbo Medvok Medical Co., Ltd. controls the entire value chain. From the internal R&D of high-purity antigens and antibodies to the final assembly of automated PCR systems, our vertical integration ensures cost-efficiency without compromising on medical-grade quality.
Our economic development is compatible with proper conduct in relation to ethics, society, the workplace, and the environment. We believe in providing clean, affordable, and reliable biotechnologies to all of society, ensuring equal rights and opportunities through our sustainability policies.
Our product pipelines are not limited to respiratory pathogens. We cover cardiovascular, inflammation, infectious diseases, tumors, and hormones. This diversity allows us to be a long-term strategic partner for comprehensive hospital laboratory upgrades.
High-throughput screening of patients presenting with acute respiratory distress. Our 12-channel and full-auto PCR systems provide clinicians with actionable data in under 2 hours, critical for triage and infection control.
The health of livestock and pets is inextricably linked to human health (One Health initiative). Our range of Veterinary medicines like Florfenicol and diagnostic panels for poultry respiratory diseases are essential for modern agricultural biosecurity.
Providing the raw materials (antigens/antibodies) and detection reagents necessary for the next generation of therapy and vaccine development.
Portable pathogen detection systems used at borders and transit hubs to monitor and prevent the transboundary spread of infectious diseases.
Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.
Innovation is in our DNA! Bioantibody keeps developing new technologies. Currently, our products have been delivered to more than 60 countries and cities worldwide. Using the ISO 13485 management system, the product quality is greatly trusted by customers. With the mission "Biotech For A Better Life", we are committed to innovation and providing our best solutions to our customers. We sincerely believe we could make our special contribution to human ecology and health.
As an IVD solutions provider, we have worked and will keep working intensively to support research and foment knowledge and prevention of the diseases. For us, a well-informed society is a healthier society. We care about protecting the human health and hope all of society to have access to clean, affordable, and reliable biotechnologies.
Medvok Medical
